- Diagnostics
- Friday, 05 Jun 2020
Japan to have coronavirus vaccines in use by June 2021
Drugmakers around the world are scrambling to develop a treatment or vaccine for COVID-19, the respiratory disease caused by the highly infectious new coronavirus which has so far killed nearly 400,000 people worldwide.
“We will be securing production facilities in parallel with expedited vaccine development,” Japan’s Health Minister Katsunobu Kato told reporters as he outlined plans to bring vaccines into use by the end of the first half of 2021.
Usually, plants for actual vaccine production are arranged only after the successful completion of development.
The Japanese government has earmarked 146 billion yen ($1.34 billion) for vaccine production and distribution in the second extra budget that Prime Minister Shinzo Abe’s cabinet approved last month.
Japanese pharmaceutical firms developing coronavirus vaccines include Shionogi & Co and AnGes Inc.
Related Industry Updates
Novacyt and Yourgene Healthcare companies to produce coronavirus test products in UK
Mar 25, 2020
Sepsis Diagnostics: Early Detection Saves Lives
Feb 17, 2026
Mako Medical Expands COVID-19 Testing to Help Those on the Front Lines
Apr 20, 2020
PSA Test Explained: What It Is, How It Works, and Why It Matters
Mar 27, 2026
North America Cancer Tissue Diagnostics Market Trends, Demand, Share, Analysis To 2027 By Leading Players Bio Rad Laboratories Inc., Abbott, Enzo Life Sciences, Inc., Cancer Genetics Inc.
Dec 04, 2020
Animal Health Market to Register Steady Expansion During 2020-2027 BY Merck & Co., Inc. ,BoehringerIngelheim International GmbH ,Ceva Santé Animale ,Cargill, Incorporated
Mar 30, 2021
North America Anti-Viral Therapies Market Growth Focusing on Trends & Innovations During the Period Until 2027
Dec 18, 2020
Follow us on
